Pd-l1 expression among different subtypes of chinese breast cancer patients

被引：0

作者：

Liao, Ning ^{[1
]}

Li, Cao ^{[1
]}

Wu, Jundong ^{[2
]}

Chen, Bo ^{[1
]}

Zhang, Guochun ^{[1
]}

Li, Xueri ^{[1
]}

Guo, Liping ^{[1
]}

Wei, Guangnan ^{[1
]}

Lin, Jiali ^{[1
]}

Li, Yingzi ^{[1
]}

Zhang, Yuchen ^{[1
]}

Mok, Hsiaopei ^{[1
]}

Ren, Chongyang ^{[1
]}

Wang, Yulei ^{[1
]}

Li, Kai ^{[1
]}

Li, Cheukfai ^{[1
]}

Wen, Lingzhu ^{[1
]}

Jia, Minghan ^{[1
]}

Lin, Tengjiao ^{[3
]}

Cheng, Chunyan ^{[3
]}

机构：

[1] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Dept Breast Canc, Guangzhou, Peoples R China

[2] Shantou Univ, Coll Med, Canc Hosp, Guangdong Prov Key Lab Breast Canc Diag & Treatme, Shantou, Peoples R China

[3] OrigiMed, Shanghai, Peoples R China

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS17-44

引用

页数：1

共 50 条

[41] PD-L1 testing in breast cancer
Horii, Rie
ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
[42] PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
Darga, Elizabeth P.
Dolce, Emily M.
Fang, Fang
Kidwell, Kelley M.
Gersch, Christina L.
Kregel, Steven
Thomas, Dafydd G.
Gill, Anoop
Brown, Martha E.
Gross, Steven
Connelly, Mark
Holinstat, Michael
Cobain, Erin F.
Rae, James M.
Hayes, Daniel F.
Paoletti, Costanza
PLOS ONE, 2021, 16 (11):
[43] PD-L1 expression on circulating tumor cells and prognosis of breast cancer patients.
Wang, Xuefei
Zhang, Goechao
Sun, Qiang
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[44] Clinicopathological significance of PD-L1 expression in patients with triple-negative breast cancer
Basheska, N.
Ognenoska-Jankovska, B.
HISTOPATHOLOGY, 2022, 81 : 26 - 27
[45] Assessment of PD-L1 expression in circulating tumor cells in patients with breast cancer.
Chen, Junqing
Chen, Zhanhong
Wang, Xiaojia
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[46] MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Breast Cancer Patients
Maniaci, Joseph
Mills, Anne
Dillon, Patrick
Gaughan, Elizabeth
Jenkins, Taylor
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 160 - 161
[47] MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Breast Cancer Patients
Maniaci, Joseph
Mills, Anne
Dillon, Patrick
Gaughan, Elizabeth
Jenkins, Taylor
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 160 - 161
[48] Study of PD-L1 Expression with Association of Pathological Factors and Molecular Subtypes in Breast Carcinoma
Gupta, Abhishek
Chandra, Smita
Chauhan, Neena
Arora, Anshika
JOURNAL OF LABORATORY PHYSICIANS, 2022, 14 (04) : 491 - 496
[49] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Sun, Woo Young
Lee, Yu Kyung
Koo, Ja Seung
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[50] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Kim, H. -M.
Sun, W. -Y.
Lee, Y. -K.
Koo, J. -S.
VIRCHOWS ARCHIV, 2016, 469 : S55 - S55

← 1 2 3 4 5 →